Allspring Global Investments Holdings LLC Lowers Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Allspring Global Investments Holdings LLC lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 22,408 shares of the company’s stock after selling 2,285 shares during the period. Allspring Global Investments Holdings LLC’s holdings in GE HealthCare Technologies were worth $1,756,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in GEHC. Blue Trust Inc. lifted its holdings in GE HealthCare Technologies by 9.9% during the third quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock valued at $219,000 after purchasing an additional 210 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in GE HealthCare Technologies by 42.5% during the third quarter. Sequoia Financial Advisors LLC now owns 13,217 shares of the company’s stock valued at $1,240,000 after purchasing an additional 3,941 shares in the last quarter. Signaturefd LLC lifted its holdings in GE HealthCare Technologies by 4.0% during the third quarter. Signaturefd LLC now owns 4,524 shares of the company’s stock valued at $425,000 after purchasing an additional 174 shares in the last quarter. Greenleaf Trust lifted its holdings in shares of GE HealthCare Technologies by 1.7% in the third quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock worth $715,000 after buying an additional 124 shares in the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in shares of GE HealthCare Technologies by 10,227.3% in the third quarter. International Assets Investment Management LLC now owns 621,913 shares of the company’s stock worth $58,367,000 after buying an additional 615,891 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.1 %

Shares of GEHC opened at $91.09 on Friday. The company’s fifty day moving average is $85.05 and its 200 day moving average is $85.86. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The stock has a market capitalization of $41.66 billion, a PE ratio of 21.04, a P/E/G ratio of 3.19 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on GEHC shares. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.